Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00495040 · ClinicalTrials.gov registry record · Phase 2
Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 38
- Enrollment target
NCT00495040: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT00495040 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00495040, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 38 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if escalated/accelerated proton radiotherapy can improve the control of Non-Small Cell Lung Cancer (NSCLC) and decrease side effects. The safety of this treatment will also be studied. Objectives: To assess the therapeutic efficacy and toxicities of proton radiotherapy with escalated/accelerated dose for patients with medically inoperable stage I (T1-2, N0,M0) NSCLC. Primary goals: 1. Improve 2 years progression free survival at the primary site, and 2. reduce acute and chronic toxicity Secondary goals: 1. Improve disease specific survival at 2 years. 2. Study the potential of pre- and post treatment PET/CT in predicting clinical outcome. 3. Study the role of biomarkers in predicting therapeutic response and toxicities.
Interventions
- RADIATION Proton Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2006-05-04 |
| Est. Completion | 2017-06-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00495040
The ClinicalTrials.gov registry entry for NCT00495040 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proton Radiotherapy is the first listed.
NCT00495040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00495040 about?
NCT00495040 is a clinical study titled "Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)". The goal of this clinical research study is to learn if escalated/accelerated proton radiotherapy can improve the control of Non-Small Cell Lung Cancer (NSCLC) and decrease side effects. The safety of this treatment will also be studied. Objectives: To assess the therapeutic efficacy and toxicitie...
What is the current status of trial NCT00495040?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 2006-05-04. Estimated completion is 2017-06-14.
What interventions are being tested in trial NCT00495040?
The interventions under investigation include: Proton Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT00495040?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.